New Drug May Help Slow Effects of Alzheimer's for Those with Mild Symptoms | University of Utah Health
To date, lecanemab is the first traditional approval of a treatment for Alzheimer’s disease. Lecanemab holds promise for patients in early stages of the disease.
Source: utah.edu